Evaluation of Extracorporeal Shockwave Therapy and Complex Decongestive Therapy Results in Patients With Lipedema

Last updated: August 24, 2025
Sponsor: Giresun University
Overall Status: Completed

Phase

N/A

Condition

Pain

Treatment

Complex Decongestive Therapy

Extracorporeal Shockwave Therapy

Clinical Study ID

NCT06898125
13.03.2023/16
  • Ages > 18
  • Female

Study Summary

The aim of the study is to evaluate the results of the Extracorporeal Shockwave Therapy and Complex Decongestive Therapy in patient diagnosed with lipedema.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Female

  • 18 years or older

  • Being diagnosed with lipedema according to Wold criteria

  • Having type 1, 2 and 3 lipedema

  • Having stage 1, 2 and 3 lipedema

Exclusion

Exclusion Criteria:

  • Known rheumatic, endocrinological, neuromuscular, dermatological disease, kidneyfailure, liver failure and malignancy

  • Having undergone surgery for lipedema

  • Having poor circulation, open wound or infection in the lower extremities

Study Design

Total Participants: 33
Treatment Group(s): 2
Primary Treatment: Complex Decongestive Therapy
Phase:
Study Start date:
September 01, 2023
Estimated Completion Date:
June 01, 2025

Study Description

The collected content will be transferred over SPSS 21.0. The normality distribution of the data will be evaluated with the Shapiro-Wilk Test. Data will be displayed as mean±standard deviation, median (1st quartile-3 quartile), or number(percent). In comparisons between the two consuming variables before and after exercise, if the values fit the normal distribution, the "paires sample t test" is used, if not, the Wilcoxon test is used. In the comparison of 3 groups, one-way ANOVA will be applied if it is normally distributed, and if it does not fit the normal distribution, the Kruskal Wallis test will be applied. Post-hoc analysis was planned for the printer, which was determined to determine the method statistically. To compare categorical protections is to use the Chi-square test. P < 0.05 will be considered future.

Connect with a study center

  • Giresun University Training and Research Hospital

    Giresun,
    Turkey

    Site Not Available

  • Giresun University Training and Research Hospital

    Giresun 746881,
    Turkey (Türkiye)

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.